This inventor holds 2 USPTO granted patents. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2010.
Location History:
- Pomezia, IT (2010)
- Calvi Risorta-Petrulo, IT (2010)
Company Filing History:
Years Active: 2010
Title: Antonio Inforzato: Innovator in Therapeutic Proteins
Introduction
Antonio Inforzato is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of therapeutic proteins, particularly through his innovative patents. With a total of 2 patents, Inforzato's work focuses on advancements that have the potential to improve treatment options for various diseases.
Latest Patents
Inforzato's latest patents include the development of deglycosylated and desialidated long pentraxin PTX3. These patents disclose processes for the preparation of these proteins, as well as pharmacological compositions that contain them. The use of these proteins is particularly indicated for the treatment of infectious and inflammatory diseases, as well as female fertility disorders. Notably, these proteins exhibit therapeutic activity that surpasses that of glycosylated pentraxin.
Career Highlights
Antonio Inforzato is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he continues to contribute to the field of pharmaceuticals. His work is characterized by a commitment to developing innovative solutions that address critical health issues.
Collaborations
Inforzato collaborates with esteemed colleagues such as Paolo Carminati and Rita De Santis. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Antonio Inforzato's contributions to the field of therapeutic proteins highlight his role as an influential inventor. His innovative patents pave the way for improved medical treatments, showcasing the importance of research and collaboration in advancing healthcare solutions.